A study to investigate safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of AZD1613 in healthy participants.

Trial Identifier:	D9050C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	June 2025
Primary Completion Date:	October 2026
Study Completion Date:	October 2026
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.